Improving the detection, diagnosis, and treatment of diseases like cancer will require more detailed, rapid, and agile imaging technology that can show doctors not just what a specific organ looks like, but also what's happening within the cells that make up those tissues.
In research published in Proceedings of the National Academy of Sciences, a team demonstrated a new technique for fluorescence lifetime imaging of tissue and cells in a fast and comprehensive manner -- laying the groundwork for use in a clinical setting.
"We are providing tools that are going to be far more amenable for the end users, meaning the biologists, but also the surgeon," said the senior author.
Fluorescence lifetime imaging has long been a helpful way for scientists and engineers to see molecular-level interactions within cells -- a necessary tool when trying to identify cancer and other diseases, and evaluate the effectiveness of drugs.
Traditionally producing an image this way has required a lot of time and complex mathematical tools that rely heavily on the user, which makes it hard to produce consistent and reproducible images. Those difficulties have been barriers to using this type of imaging in a clinical setting.
To overcome those challenges, the team designed a deep neural network (DNN) to automatically set the mathematical parameters that a human typically would, while also producing a detailed image that can show interactions in cells or tissue as they're happening.
This work builds on the team's earlier work, where they developed a method for quickly reconstructing a single lifetime image. This new approach reconstructs multiple lifetime images at the same time, providing a comprehensive view of multiple biological processes happening within the tissue and cells, said another author.
The team, in partnership with biologists, tested this new technique by imaging cancer cells under the microscope and in living systems. What they observed was that their DNN performed as well as, or in some cases better than, commercial software currently being used. The team also found this technique required less light while still producing detailed images, which is critical for biological applications.
The researchers' success brings the field closer to being able to use fluorescence lifetime imaging in a clinical setting in order to evaluate the effectiveness of a particular drug on a person's individual cancer cells -- a key tool needed to enable precision medicine.
The researchers also were able to apply this DNN to visualize the level of activity within cells, a process known as metabolic imaging. This approach could help guide surgeons in the operating room as they work to identify which tissue is healthy, and which is diseased and should be removed.
"This is an enabling technology for many clinical applications. For instance, it may be used for in vivo real-time imaging of a tumor, which may help surgeons see the lesion during their procedures, enabling them to completely remove cancer tissue with minimal damage to healthy tissue," the senior author said.
https://news.rpi.edu/content/2019/11/13/new-technique-aims-improve-imaging-cells
https://www.pnas.org/content/early/2019/11/11/1912707116
In research published in Proceedings of the National Academy of Sciences, a team demonstrated a new technique for fluorescence lifetime imaging of tissue and cells in a fast and comprehensive manner -- laying the groundwork for use in a clinical setting.
"We are providing tools that are going to be far more amenable for the end users, meaning the biologists, but also the surgeon," said the senior author.
Fluorescence lifetime imaging has long been a helpful way for scientists and engineers to see molecular-level interactions within cells -- a necessary tool when trying to identify cancer and other diseases, and evaluate the effectiveness of drugs.
Traditionally producing an image this way has required a lot of time and complex mathematical tools that rely heavily on the user, which makes it hard to produce consistent and reproducible images. Those difficulties have been barriers to using this type of imaging in a clinical setting.
To overcome those challenges, the team designed a deep neural network (DNN) to automatically set the mathematical parameters that a human typically would, while also producing a detailed image that can show interactions in cells or tissue as they're happening.
This work builds on the team's earlier work, where they developed a method for quickly reconstructing a single lifetime image. This new approach reconstructs multiple lifetime images at the same time, providing a comprehensive view of multiple biological processes happening within the tissue and cells, said another author.
The team, in partnership with biologists, tested this new technique by imaging cancer cells under the microscope and in living systems. What they observed was that their DNN performed as well as, or in some cases better than, commercial software currently being used. The team also found this technique required less light while still producing detailed images, which is critical for biological applications.
The researchers' success brings the field closer to being able to use fluorescence lifetime imaging in a clinical setting in order to evaluate the effectiveness of a particular drug on a person's individual cancer cells -- a key tool needed to enable precision medicine.
The researchers also were able to apply this DNN to visualize the level of activity within cells, a process known as metabolic imaging. This approach could help guide surgeons in the operating room as they work to identify which tissue is healthy, and which is diseased and should be removed.
"This is an enabling technology for many clinical applications. For instance, it may be used for in vivo real-time imaging of a tumor, which may help surgeons see the lesion during their procedures, enabling them to completely remove cancer tissue with minimal damage to healthy tissue," the senior author said.
https://news.rpi.edu/content/2019/11/13/new-technique-aims-improve-imaging-cells
https://www.pnas.org/content/early/2019/11/11/1912707116
Edited
Latest News
A gene that helps cancer ce…
By newseditor
Posted 17 Jun
Sleep deprivation disrupts…
By newseditor
Posted 17 Jun
Active biointegrated living…
By newseditor
Posted 17 Jun
Which of the two DNA strand…
By newseditor
Posted 16 Jun
Microglia depletion prevent…
By newseditor
Posted 16 Jun
Other Top Stories
Dopamine release is governed by self-control of neurons
Read more
Multiple sclerosis subtypes identified using artificial intelligence
Read more
Central metabolic sensor controls activation of Parkinson's protein…
Read more
Blood test for mood disorders!
Read more
Controlling parathyroid hormone (PTH)-induced bone formation
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Predictive value of neutrop…
By newseditor
Posted 17 Jun
Microbiome-derived acidity…
By newseditor
Posted 17 Jun
The Thermodynamics of Mind
By newseditor
Posted 17 Jun
Lost in translation: challe…
By newseditor
Posted 17 Jun
Pathways for macrophage upt…
By newseditor
Posted 16 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar